LTH vs. SWTX, TNDM, NVST, AMED, SGRY, PBH, ARWR, IDYA, LIVN, and SHC
Should you be buying Life Time Group stock or one of its competitors? The main competitors of Life Time Group include SpringWorks Therapeutics (SWTX), Tandem Diabetes Care (TNDM), Envista (NVST), Amedisys (AMED), Surgery Partners (SGRY), Prestige Consumer Healthcare (PBH), Arrowhead Pharmaceuticals (ARWR), IDEAYA Biosciences (IDYA), LivaNova (LIVN), and Sotera Health (SHC). These companies are all part of the "medical" sector.
SpringWorks Therapeutics (NASDAQ:SWTX) and Life Time Group (NYSE:LTH) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings.
In the previous week, SpringWorks Therapeutics had 2 more articles in the media than Life Time Group. MarketBeat recorded 7 mentions for SpringWorks Therapeutics and 5 mentions for Life Time Group. Life Time Group's average media sentiment score of 1.03 beat SpringWorks Therapeutics' score of 0.17 indicating that SpringWorks Therapeutics is being referred to more favorably in the media.
Life Time Group has higher revenue and earnings than SpringWorks Therapeutics. SpringWorks Therapeutics is trading at a lower price-to-earnings ratio than Life Time Group, indicating that it is currently the more affordable of the two stocks.
79.4% of Life Time Group shares are owned by institutional investors. 7.6% of SpringWorks Therapeutics shares are owned by insiders. Comparatively, 12.5% of Life Time Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
SpringWorks Therapeutics received 75 more outperform votes than Life Time Group when rated by MarketBeat users. Likewise, 68.18% of users gave SpringWorks Therapeutics an outperform vote while only 25.00% of users gave Life Time Group an outperform vote.
SpringWorks Therapeutics presently has a consensus price target of $68.83, indicating a potential upside of 64.40%. Life Time Group has a consensus price target of $20.57, indicating a potential upside of 28.33%. Given Life Time Group's stronger consensus rating and higher probable upside, analysts plainly believe SpringWorks Therapeutics is more favorable than Life Time Group.
Life Time Group has a net margin of 3.19% compared to Life Time Group's net margin of 0.00%. SpringWorks Therapeutics' return on equity of 4.38% beat Life Time Group's return on equity.
SpringWorks Therapeutics has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Life Time Group has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500.
Summary
Life Time Group beats SpringWorks Therapeutics on 10 of the 18 factors compared between the two stocks.
Get Life Time Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LTH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Life Time Group Competitors List
Related Companies and Tools
